Evropska unija - slovenščina - EMA (European Medicines Agency)

zoetis belgium sa - cefovecin (as sodium salt) - antibakterij za sistemsko uporabo - dogs; cats - dogsfor zdravljenje kože in mehkega tkiva okužbe, vključno z pyoderma, ran in abscesov, povezane s staphylococcus pseudintermedius, β-haemolytic streptococci, escherichia coli in / ali pasteurella multocida. za zdravljenje okužb sečil, povezanih z escherichia coli in / ali proteus spp. kot dodatno zdravljenje mehanske ali kirurške periodontalne terapije pri zdravljenju hudih okužb gingive in parodontalnih tkiv, povezanih s porphyromonas spp. in prevotella spp. catsfor zdravljenje kože in mehkega tkiva abscesi in rane, povezane s pasteurella multocida, usobacterium spp. , bacteroides spp. , prevotella oralis, β-haemolytic streptococci in / ali staphylococcus pseudintermedius. za zdravljenje okužb sečil, povezanih z escherichia coli.

Evropska unija - slovenščina - EMA (European Medicines Agency)

pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibacterials za sistemsko uporabo, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.

Evropska unija - slovenščina - EMA (European Medicines Agency)

zoetis belgium sa - ceftiofur - antibakterij za sistemsko uporabo - pigs; cattle - pigstreatment of bacterial respiratory disease associated with actinobacillus pleuropneumoniae, pasteurella multocida, haemophilus parasuis and streptococcus suis. zdravljenje septikemije, poliartritisa ali poliserozitisa, povezane z okužbo s streptococcus suis. cattletreatment of acute interdigital necrobacillosis in cattle also known as panaritium or foot rot. zdravljenje akutnega posttornega (puerperalnega) metritisa pri govedu, če zdravljenje z drugim protimikrobnim zdravilom ni uspelo.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

eurovet animal health bv -

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

norbrook laboratories (ireland) ltd -

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

eurovet animal health bv handelsweg 25 -

Evropska unija - slovenščina - EMA (European Medicines Agency)

immedica pharma ab - natrijev phenylbutyrate - ornithine carbamoyltransferase deficiency disease; citrullinemia; carbamoyl-phosphate synthase i deficiency disease - drugi zdravljene bolezni prebavil in presnove izdelki, - ammonaps je označen kot adjunctive terapije pri kroničnih upravljanje sečnine cikel motenj, ki vključujejo pomanjkljivosti carbamylphosphate synthetase, ornitin transcarbamylase orargininosuccinate synthetase. to je indicirana pri vseh bolnikih z novorojenčku-nastop predstavitev (skupaj encim pomanjkljivosti, ki predstavljajo v prvih 28 dneh življenja). to je prikazano tudi pri bolnikih s poznim nastopom bolezni(delna encim pomanjkljivosti, ki predstavljajo po prvem mesecu življenja), ki so zgodovino hyperammonaemic encefalopatija.

Evropska unija - slovenščina - EMA (European Medicines Agency)

ucb pharma s.a.   - bimekizumab - psoriaza - imunosupresivi - plaque psoriasisbimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisbimzelx, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)bimzelx is indicated for the treatment of adults with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

krka, d.d., novo mesto - cefotaksim - prašek za raztopino za injiciranje/infundiranje - cefotaksim 2 g / 1 viala - cefotaksim

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

krka, d.d., novo mesto - cefotaksim - prašek za raztopino za injiciranje/infundiranje - cefotaksim 1 g / 1 viala - cefotaksim